BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 29958117)

  • 1. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary intake, drinking water ingestion and plasma perfluoroalkyl substances concentration in reproductive aged Chinese women.
    Zhou W; Zhao S; Tong C; Chen L; Yu X; Yuan T; Aimuzi R; Luo F; Tian Y; Zhang J;
    Environ Int; 2019 Jun; 127():487-494. PubMed ID: 30981019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: Implications for risk assessment.
    Wang B; Chen Q; Shen L; Zhao S; Pang W; Zhang J
    Environ Int; 2016 Dec; 97():7-14. PubMed ID: 27770709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.